about
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancerIdentification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profilingIntegrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including DroshaGLO1-A novel amplified gene in human cancerArchitectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolutionChromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinomaCombined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsGenome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcomaSelection in the evolution of gene duplicationsAmplification of Cellular Oncogenes in Solid TumorsNon-coding RNAs in lung cancerEGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronucleiMurine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci.A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.Methods of molecular analysis: assessing losses and gains in tumoursHigh rate of CAD gene amplification in human cells deficient in MLH1 or MSH6.Increased sensitivity of subtelomeric regions to DNA double-strand breaks in a human cancer cell lineA chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17.Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease.Altered expression of KCNK9 in colorectal cancers.Cancer genetics and tumor antigens: time for a combined view?Genome wide measurement of DNA copy number changes in neuroblastoma: dissecting amplicons and mapping losses, gains and breakpoints.The role of oncogenes in gastrointestinal cancer.XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line.Subtelomeric regions in mammalian cells are deficient in DNA double-strand break repair.Cancer gene discovery in mouse and man.The role of DNA breaks in genomic instability and tumorigenesis.Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesisChromosomal instability in oral cancer cells.Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.Nuclear architecture in the light of gene expression and cell differentiation studies.Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells.Telomerase-dependent and -independent chromosome healing in mouse embryonic stem cellsSmall nucleolar RNAs in cancer.Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma.
P2860
Q21093289-1D47A6AC-067B-48A5-9E68-AD5B2DE9A164Q21245710-AF3C0BD1-3FCA-4EBA-99FB-C4381427AECAQ21245740-C10CE805-E09E-4F7E-BFA5-386E932C897FQ24322023-B1A7646E-A7B3-4FC0-8D64-50EBAD65A302Q24631249-675D7578-1E45-42B0-B45F-69BBA1E03C8FQ24676904-23481B1B-B272-4CEB-A90F-6363CD784524Q24799110-759E72D5-0376-4738-8544-C3C180FF0D12Q24799947-2E989ADD-F68B-4CDC-A427-65BA7C33AA46Q24801656-F27BCA2A-A3FD-4306-A182-C87436E9F2A5Q24802293-62E77BB2-F93A-41A1-994D-A7BC4311F81DQ26784582-F7B702BD-505B-496E-9254-B0BE2947B91CQ26866521-0A8BCCCA-D721-4665-A840-668479A1DE3BQ27851658-BC62AE29-3EAE-4EDD-830A-C87481426FA0Q28364316-CE8EC910-A08D-40D6-BB54-B7DE30E237E8Q30744989-B7EDBEA9-35DF-4A51-8A0F-E78C4C80BA7EQ33739397-3A470450-283C-4EAF-8A53-18A0B36DB239Q33882364-A7226BE3-8160-4090-B057-E9B41C6C05CAQ33889856-8F85403A-F5A1-4131-8EB7-AD93A939FF3AQ33918898-CC601A5E-A22F-46A7-8C8E-83381C5494ABQ33950079-61F0190D-729D-41D3-A176-F16FC90FF458Q33980522-65782C6C-401F-4350-B13F-B8A16F998EC2Q34080017-038972FE-4F07-4264-8875-DACD174EA293Q34294497-F52D51B6-048D-40DB-A9FB-70D8884795E4Q34376745-76CB0C4A-B277-4651-888E-00E5CADF3182Q34495646-98729FF5-9CDA-48A9-A55B-10B1522BEEB6Q34584301-1716B4F4-444E-43D9-AFF4-7AEF8423BEFBQ34616409-96198D27-1FD2-4686-ACFD-8A3BA3496775Q34624530-76CF280D-D6E9-4A4E-B144-20A8226121CAQ34775818-C9CF6B2B-119A-4618-8D20-3E5584CA2C2FQ34883924-915E8478-3809-4AC6-A0BA-7061AED1ABB3Q34962407-2FBC46E1-4375-4E31-85EA-5C9D48B25F71Q35170919-78DF8BE6-E6AF-43E2-9972-54905267A955Q35589281-A800D478-44C3-469E-894C-9A420F28B223Q36019105-ACAD63FB-0AF7-4EB8-801C-BB7589D52932Q36214558-F4E89231-7AB0-4F41-A4E0-6C893D8520C4Q36480533-F46C5BB0-305E-41CD-BE84-FF8FE011D3E9Q36616716-C1C91D75-9599-49F1-98B4-DA7ACAE5E4A4Q37002134-79DD5E21-D58E-4C57-B9EC-76C155EEC038Q37346566-F9A700D5-9B87-482F-A632-81103E25534AQ37372476-FA6D7364-08C5-47A1-890B-D8F9E16BF4D0
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Oncogene amplification in solid tumors.
@ast
Oncogene amplification in solid tumors.
@en
type
label
Oncogene amplification in solid tumors.
@ast
Oncogene amplification in solid tumors.
@en
prefLabel
Oncogene amplification in solid tumors.
@ast
Oncogene amplification in solid tumors.
@en
P356
P1476
Oncogene amplification in solid tumors.
@en
P2093
P304
P356
10.1006/SCBI.1999.0126
P577
1999-08-01T00:00:00Z